SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024138
Filing Date
2022-11-10
Accepted
2022-11-10 07:01:27
Documents
53
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nuvl-20220930.htm   iXBRL 10-Q 3447374
2 EX-31.1 nuvl-ex31_1.htm EX-31.1 21528
3 EX-31.2 nuvl-ex31_2.htm EX-31.2 21526
4 EX-32.1 nuvl-ex32_1.htm EX-32.1 13590
5 EX-32.2 nuvl-ex32_2.htm EX-32.2 11623
  Complete submission text file 0000950170-22-024138.txt   7881648

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nuvl-20220930_pre.xml EX-101.PRE 225671
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nuvl-20220930_lab.xml EX-101.LAB 280129
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nuvl-20220930.xsd EX-101.SCH 31534
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nuvl-20220930_def.xml EX-101.DEF 179078
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nuvl-20220930_cal.xml EX-101.CAL 28158
47 EXTRACTED XBRL INSTANCE DOCUMENT nuvl-20220930_htm.xml XML 1098151
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40671 | Film No.: 221374853
SIC: 2834 Pharmaceutical Preparations